On the public citation graph
Association of nicotine metabolism and sex with relapse following varenicline and nicotine replacement therapy.
0 signed · 60 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
1 of the 45 references listed on this page is in the Retraction Watch database as retracted (export 2026-11-04): 10.1002/14651858.cd008033.pub3 (notice 2019-10-01).
Dataset join, best-effort; this page does not check the publisher record. Retraction Watch data via Crossref Labs, used with credit; OpenCitations Index (CC0) and Meta (CC BY 4.0); dataset doi:10.7910/DVN/WT8VOA (CC BY 4.0).
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/14651858.cd005231.pub3openalex-snapshot
Interventions to reduce harm from continued tobacco use
inferredcites →https://doi.org/10.1002/14651858.cd008033.pub3openalex-snapshot
Reduction versus abrupt cessation in smokers who want to quit
inferredcites →https://doi.org/10.1002/14651858.cd009329.pub2openalex-snapshot
Pharmacological interventions for smoking cessation: an overview and network meta-analysis
inferredcites →https://doi.org/10.1006/bbrc.2001.4990openalex-snapshot
Identification of a Single Nucleotide Polymorphism in the TATA Box of the CYP2A6 Gene: Impairment of Its Promoter Activity
inferredcites →https://doi.org/10.1016/j.amepre.2008.04.009openalex-snapshot
A Clinical Practice Guideline for Treating Tobacco Use and Dependence: 2008 Update
inferredcites →https://doi.org/10.1016/j.clpt.2004.02.011openalex-snapshot
Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity*1
inferredcites →https://doi.org/10.1016/j.clpt.2006.01.008openalex-snapshot
Female sex and oral contraceptive use accelerate nicotine metabolism
inferredcites →https://doi.org/10.1016/j.clpt.2006.08.011openalex-snapshot
CYP2A6 genotype and the metabolism and disposition kinetics of nicotine
inferredcites →https://doi.org/10.1016/j.jchromb.2011.09.046openalex-snapshot
Quantification of nicotine, cotinine, trans-3′-hydroxycotinine and varenicline in human plasma by a sensitive and specific UPLC–tandem mass-spectrometry procedure for a clinical study on smoking cessation
inferredcites →https://doi.org/10.1016/j.mayocp.2012.11.013openalex-snapshot
Comparison of the Effectiveness of Varenicline and Combination Nicotine Replacement Therapy for Smoking Cessation in Clinical Practice
inferredcites →https://doi.org/10.1016/j.pbb.2008.10.016openalex-snapshot
Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: A validation study
inferredcites →https://doi.org/10.1016/s0022-3565(24)36947-2openalex-snapshot
A Major Role for CYP2A6 in Nicotine C-Oxidation by Human Liver Microsomes
inferredcites →https://doi.org/10.1016/s0022-3565(25)12887-5openalex-snapshot
Characterization of CYP2A6 involved in 3'-hydroxylation of cotinine in human liver microsomes.
inferredcites →https://doi.org/10.1016/s0076-6879(02)57666-7openalex-snapshot
Genotyping human CYP2A6 variants
inferredcites →https://doi.org/10.1016/s2213-2600(14)70294-2openalex-snapshot
Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial
inferredcites →https://doi.org/10.1021/bi00457a031openalex-snapshot
The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes
inferredcites →https://doi.org/10.1037/a0037692openalex-snapshot
Consideration of sex in clinical trials of transdermal nicotine patch: A systematic review.
inferredcites →https://doi.org/10.1038/clpt.2011.70openalex-snapshot
Impact of Smoking, Smoking Cessation, and Genetic Polymorphisms on CYP1A2 Activity and Inducibility
inferredcites →https://doi.org/10.1056/nejmcp1101512openalex-snapshot
Treating Smokers in the Health Care Setting
inferredcites →https://doi.org/10.1080/01677060802572887openalex-snapshot
Nicotine Dependence Pharmacogenetics: Role of Genetic Variation in Nicotine-Metabolizing Enzymes
inferredcites →https://doi.org/10.1080/14622200600789726openalex-snapshot
Does smoking reduction increase future cessation and decrease disease risk? A qualitative review
inferredcites →https://doi.org/10.1080/14622200802097506openalex-snapshot
Sex differences in long-term smoking cessation rates due to nicotine patch
inferredcites →https://doi.org/10.1093/biomet/81.3.515openalex-snapshot
Proportional Hazards Tests and Diagnostics Based on Weighted Residuals
inferredcites →https://doi.org/10.1093/ntr/ntu335openalex-snapshot
Innovations in Translational Sex and Gender-Sensitive Tobacco Research
inferredcites →https://doi.org/10.1093/ntr/ntv125openalex-snapshot
The Nicotine Metabolite Ratio is Associated With Early Smoking Abstinence Even After Controlling for Factors That Influence the Nicotine Metabolite Ratio
inferredcites →https://doi.org/10.1093/ntr/ntw144openalex-snapshot
Sex Differences in Smoking Cessation Pharmacotherapy Comparative Efficacy: A Network Meta-analysis
inferredcites →https://doi.org/10.1097/01.fpc.0000171517.22258.f1openalex-snapshot
Three haplotypes associated with CYP2A6 phenotypes in Caucasians
inferredcites →https://doi.org/10.1097/fpc.0b013e328336eee4openalex-snapshot
ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir
inferredcites →https://doi.org/10.1111/add.12219openalex-snapshot
Fifty-two-week continuous abstinence rates of smokers being treated with varenicline versus nicotine replacement therapy
inferredcites →https://doi.org/10.1111/add.12895openalex-snapshot
An exploratory short‐term double‐blind randomized trial of varenicline versus nicotine patch for smoking cessation in women
inferredcites →https://doi.org/10.1111/j.1360-0443.1991.tb01879.xopenalex-snapshot
The Fagerström Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire
inferredcites →https://doi.org/10.1124/dmd.107.016568openalex-snapshot
Human CYP2A6 Is Induced by Estrogen via Estrogen Receptor
inferredcites →https://doi.org/10.1136/bmj.b1024openalex-snapshot
Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis
inferredcites →https://doi.org/10.1136/tc.2005.011932openalex-snapshot
Health consequences of smoking 1–4 cigarettes per day
inferredcites →https://doi.org/10.1136/thx.2007.090647openalex-snapshot
Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial
inferredcites →https://doi.org/10.1158/1055-9965.epi-05-0723openalex-snapshot
CYP2A6Genotype, Phenotype, and the Use of Nicotine Metabolites as Biomarkers duringAd libitumSmoking
inferredcites →https://doi.org/10.1158/1055-9965.epi-14-0427openalex-snapshot
Known and Novel Sources of Variability in the Nicotine Metabolite Ratio in a Large Sample of Treatment-Seeking Smokers
inferredcites →https://doi.org/10.1176/appi.ajp.2014.13050595openalex-snapshot
Combination Treatment With Varenicline and Bupropion in an Adaptive Smoking Cessation Paradigm
inferredcites →https://doi.org/10.1176/appi.ajp.2014.14081032openalex-snapshot
Smoking Cessation in Men and Women
inferredcites →https://doi.org/10.1176/appi.ajp.2015.14111429openalex-snapshot
Sex Difference in Response to Varenicline for Smoking Cessation
inferredcites →https://doi.org/10.1186/s12889-016-3672-yopenalex-snapshot
Gender difference and effect of pharmacotherapy: findings from a smoking cessation service
inferredcites →https://doi.org/10.2217/14622416.8.10.1385openalex-snapshot
Genetic Variability in CYP2A6 and the Pharmacokinetics of Nicotine
inferredcites →https://doi.org/10.2217/14622416.8.6.623openalex-snapshot
ADME Pathway Approach for Pharmacogenetic Studies of Anti-HIV Therapy
inferredcites →https://doi.org/10.5588/ijtld.11.0183openalex-snapshot
Quitting smoking with varenicline: parallel, randomised efficacy trial in Iran
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4632941openalex-extracted
Association between Nicotine Metabolite Ratio and Smoking Cessation Medications in Chinese Male Smokers - Results of the China National Tobacco Cessation Cohort Study
inferred← citeshttps://doi.org/10.1007/978-3-030-71929-6_5openalex-snapshot
Tobacco Blinders: How Tobacco Control Remained Generic for Far Too Long
inferred← citeshttps://doi.org/10.1016/j.addicn.2023.100076openalex-snapshot
The use of biomarkers to guide precision treatment for tobacco use
inferred← citeshttps://doi.org/10.1016/j.brainresbull.2022.06.007openalex-snapshot
Genetic influences impacting nicotine use and abuse during adolescence: Insights from human and rodent studies
inferred← citeshttps://doi.org/10.1016/j.dadr.2023.100177openalex-snapshot
Sex effects in predictors of smoking abstinence and neuropsychiatric adverse events in the EAGLES trial
inferred← citeshttps://doi.org/10.1016/j.hsr.2024.100186openalex-snapshot
The impact of rate of nicotine metabolism, as measured by the nicotine metabolite ratio (NMR), on smoking behaviours during pregnancy: A scoping review
inferred← citeshttps://doi.org/10.1080/17476348.2024.2429675openalex-snapshot
Is the nicotine metabolite ratio a useful tool to improve the effectiveness, safety, and adherence to quitting smoking? Systematic review of the literature and meta-analysis
inferred← citeshttps://doi.org/10.1111/resp.14702openalex-snapshot
Efficacy of varenicline or bupropion and its association with nicotine metabolite ratio among smokers with COPD
inferred← citeshttps://doi.org/10.1146/annurev-clinpsy-081219-090343openalex-snapshot
Smoking Treatment: A Report Card on Progress and Challenges
inferred← citeshttps://doi.org/10.1158/1940-6207.capr-19-0259openalex-snapshot
The Use of the Nicotine Metabolite Ratio as a Biomarker to Personalize Smoking Cessation Treatment: Current Evidence and Future Directions
inferred← citeshttps://doi.org/10.11606/t.5.2022.tde-03102022-124014openalex-snapshot
Avaliações farmacogenética e da relação de metabólitos da nicotina em pacientes tratados com fármacos antitabagismo
inferred← citeshttps://doi.org/10.3389/fgene.2023.1103966openalex-snapshot
A scoping review of smoking cessation pharmacogenetic studies to advance future research across racial, ethnic, and ancestral populations
inferred← citeshttps://doi.org/10.3389/fphar.2022.900112openalex-snapshot
Evaluation of the nicotine metabolite ratio in smoking patients treated with varenicline and bupropion
inferred← citeshttps://doi.org/10.3390/ijerph17030872openalex-snapshot
Sex- and Gender-Based Analysis in Cannabis Treatment Outcomes: A Systematic Review
inferred← citeshttps://doi.org/10.3390/ijerph18126597openalex-snapshot
Genetic Variants in Smoking-Related Genes in Two Smoking Cessation Programs: A Cross-Sectional Study
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.